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Abstract 
West Nile virus (WNV) is one of the most common causes of epidemic viral encephalitis in horses worldwide. Periph‑
eral blood mononuclear cells (PBMCs) are amongst the first to encounter the virus following a mosquito bite. This 
study aimed to elucidate the transcription kinetics of cytokine, Toll‑like receptor (TLRs) and TLRs‑associated genes fol‑
lowing WNV challenge of equine PBMCs. PBMCs were challenged with an Australian strain of WNV (WNVNSW2011) and 
transcriptomes were quantified at 2, 6, 12 and 24 h post‑infection (pi) using qRT‑PCR. Type I and II interferons (IFNα, 
β and γ) mRNA transcription increased following WNV exposure, as did the transcripts for IL1α, IL1β, IL6, IL8, and IL22, 
but with slightly varying kinetics. TLR1, 3, 5, 7‑9 transcripts were also upregulated in equine PBMCsin response to WNV 
challenge, as were those for MyD88, NF‑κB, TRAF3, STAT1 and 2, IRF3 and 7, ISG15, as well as SOCS1 and 3 compared 
to the control cells. Expression of selected genes in the draining lymph node, spleen and brain (medulla oblongata) of 
experimentally infected horses was also assessed and transcription of most of these genes was also upregulated here. 
Although qRT‑PCR detected higher viral RNA at 24 h pi compared to 6 h pi, the virus did not replicate productively in 
equine PBMCs. The up‑regulation of gene‑transcription for selected cytokines, IFNs, TLRs and TLRs‑associated mol‑
ecules suggests their involvement in virus recognition and control of WNV infection in the horse.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
West Nile virus (WNV), a mosquito-borne flavivirus, is 
widely distributed throughout Africa, the Middle East, 
Asia, Southern Europe, the Americas and Australia 
[1]. Since the first isolation of the Australian strain of 
WNV—Kunjin strain (WNVKUN) in 1960 in North 
Queensland [2], it has been found to be endemic in Aus-
tralia [3]. WNVKUN belongs to lineage 1 of WNV, which 
also contains the highly pathogenic, neuroinvasive New 
York 99 strain (WNVNY99) [4]. From 1999 to 2014, a total 
of 38 259 humans infections with 1654 deaths and more 
than 20 000 equine deaths of WNV disease have been 
reported in the USA [5]. Relative to the WNVNY99 strain, 
WNVKUN exhibits much reduced virulence in humans, 
animals, and birds. In early 2011 following extensive 
flooding in the Murray-Darling River basin and other 
inland river systems of South-East Australia, an unprec-
edented outbreak of equine encephalitis occurred in 
south-eastern Australia involving more than 1000 horses 
[4]. Only a few human clinical cases occurred at the time 
and none were fatal. Genomic sequencing of viruses iso-
lated from affected horses and mosquitoes in the 2011 
outbreak revealed the aetiological agent to be a variant 
strain of WNV, most closely related to WNVKUN and 
indicating local origin [4]. The new strain was named 
WNVNSW2011. At the genetic level, WNVNSW2011 is 
more than 98% homologous in amino acid sequence to 
WNVNY99 [4]. Recently it was found that WNV remains a 
potential threat to human and animal health in Australia 
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[6], however, despite its importance much remains 
unknown regarding the host-virus relationship in the tar-
get species, humans and equines [7].
To survive virus infection, the host must recognise 
invasion and develop an effective antiviral immune 
response. This response is initiated in infected cells after 
detection of virus by specific, conserved host molecules, 
such as Toll-like receptors (TLRs) which trigger signal-
ling cascades that induce the activation of transcription 
factor NF-κB, IFN regulatory factors (IRFs), including 
IFNs and hundreds of different IFN-stimulated effec-
tor genes (ISGs) [8]. The involvement of TLR3 [9], 7 
[10] and 9 [11] in WNV infection has been widely stud-
ied in mice and humans. MyD88, NF-κB, STAT, ISG15, 
IRF7and 9 [12–16] are crucially involved in the recogni-
tion and induction of host immune response to WNV. As 
a result of successful recognition of WNV by TLRs and 
associated genes, cytokine andIFN cascades are activated 
to prevent the early stages of WNV replication [17]. The 
ISG products include antiviral effector molecules and 
immunomodulatory cytokines that serve to restrict virus 
replication and modulate the adaptive immune response 
[15]. However, these signalling pathways have been stud-
ied predominantly in mice (reviewed in [8]), with only 
limited studies in horses [18]. WNV typically produce 
severe encephalitis and death in mice (reviewed in [19]), 
while most WNV infections in humans and horses are 
subclinical [20–22]. The transcriptome profile in small 
animal models may therefore not reflect what happens 
in the majority of human and equine infections, thus 
warranting alternative models [23]. Furthermore, while 
WNVNY99 causes severe neuropathology and death in 
mice, WNVKUN mostly causes only subclinical infection 
in horses and rabbits [23].
Identification of molecules that may be involved in 
limiting virus growth and contributing to host sur-
vival is therefore crucial to understand the host-patho-
gen interactions of subclinical infection. Therefore, we 
hypothesised that WNVKUN induces a pattern of innate 
immune responses, which might help to elucidate the 
host-pathogen interactions of intermediate virulent 
flaviviruses [23–25]. Furthermore, the virus in most 
natural cases of equine WNV encephalitis is undetect-
able in the central nervous system (CNS) at the time of 
clinical symptoms appearing [20, 21] suggesting that an 
early innate immune response may bean important fac-
tor for limiting CNS infection and survival of horses 
[26]. Peripheral blood mononuclear cells (PBMCs) are 
amongst the first immune components to encounter 
WNV following a mosquito bite. It has been suggested 
that the equine PBMCs may serve as target cells for 
North American strains of WNV and play a role in sub-
sequent viral dissemination [27]. Therefore, the current 
study aimed at assessing the kinetics of innate immune 
molecule transcripts activated at early time points fol-
lowing WNVNSW2011 infection of equine PBMCs. For this 
purposes, WNVNSW2011 stimulated equine PBMCs were 
cultured for 24  h and gene transcripts, which might be 




The WNVNSW2011 strain used in this study has previ-
ously been characterized and described in detail [4]. Two 
additional passages of the virus were performed in C6/36 
mosquito (Aedes albopictus) cells cultured in RPMI-1640 
media with 2% foetal bovine serum (FBS) at 28 °C with-
out CO2 [28]. The virus stock was stored at −80 °C. The 
titre of the stock was quantified using standard plaque 
assay on Vero cells, as described previously [28]. Briefly, 
samples were serially diluted in PBS in the range 1:103 
to 1:109. Three hundred microliters (300  µL) of sample 
was added to each well of a 6-well plate with a conflu-
ent monolayer of Vero cells. The plates were incubated 
for 2 h at 37 °C, then 2 mL of overlay was added to each 
well (final concentration  =  0.5% agar with 1×  DMEM, 
2% FBS, l-glutamine [2  nM], penicillin [50  U/mL] and 
streptomycin [50  µg/mL]). Plates were incubated in a 
37  °C with 5% CO2 incubator. At 4  days post-infection 
(pi), 2 mL of 10% formaldehyde was added and incubated 
for 30 min at room temperature to fix the plate. The gel 
overlay was removed and 1 mL of 0.2% crystal violet was 
added and incubated for 30 min. Plaques were enumer-
ated using a light box. The WNVNSW2011 was diluted to 
1 × 106 PFU/50 µL for use in PBMCs infection in vitro 
experiments.
PBMC isolation, culture and challenged with viruses
The studies were approved by the University of Queens-
land Animal Ethics Committee (AEC nos. SVS/306/11/
VAXINE and SVS/298/13/VAXINE), and the Animal 
Use and Care Committee of Colorado State University 
(Approval: 12-3837A), and carried out in accordance 
with the NHMRC and NIH guidelines for ethical use of 
animals in research. EDTA-stabilized blood samples were 
collected from three healthy WNV seronegative horses 
(n =  3) [29]. Blood was collected from the jugular vein 
of horses into EDTA-coated collection tubes (Vacu-
ette®, Greiner Bio One, Australia). The PBMCs were 
isolated from the blood using Ficoll-Histopaque (Sigma) 
as described previously [25, 30]. The viability of the puri-
fied PBMCs was assessed using the trypan blue exclusion 
method and was always greater than 90%. The cells were 
counted using a haemocytometer and the concentra-
tion was adjusted to 1 × 106 cells/0.5 mL in RPMI-1460 
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supplemented with l-glutamine (2  nM), streptomycin 
(50 µg/mL) and penicillin (50 U/mL), and 10% FBS [25, 
30]. The cells were cultured in a 24-well cell culture plate 
(Costar Corning, the Netherlands) seeded with 500  µL 
cell suspension per well and at 37  °C with 5% CO2. 
Remaining PBMCs (fresh-isolated PBMCs) were pel-
leted and kept at −80 °C for RNA isolation. After 1 h of 
seeding, the PBMCs were challenged by adding 50 µL of 
WNVNSW2011 stock to each well to give a final multiplicity 
of infection (MOI) of one [7, 25, 31]. Additional 450 µL 
medium was added to each well to make up the final vol-
ume 1 mL. One well of PBMCs per animal (n = 3) was 
harvested at 2 h, 6 h, 12 h and 24 h after virus infection. 
The harvested cells (WNV-stimulated PBMCs) were 
pelleted and kept at −80 °C until subjected to RNA iso-
lation. For complete harvest of adherent PBMCs, detach-
ment with lidocaine HCl (12  mM) was performed [32]. 
To ensure the complete harvesting of cells, wells were 
checked using an inverted microscope. Duplicate wells 
of uninfected cells (mock-inoculated PBMCs) were har-
vested and treated in a similar manner at each time point.
Experimentally horse infection with WNV
Three horses (all quarterstock horses, 1–2 years old; one 
gelding and two females) seronegative for WNV were 
challenged by intradermal inoculation of 3  ×  104 PFU 
of WNVNSW2011. Horses were euthanatized 12  days pi 
[33]. Samples from CNS (medulla oblongata), spleen and 
lymph nodes (the injection-site draining pre-scapular) 
were collected at necropsy for RNA isolation, histopa-
thology assessment and immunohistochemistry.
RNA isolation, cDNA synthesis and transcriptome 
quantification
Total RNA was isolated from PBMCs using miRN easy 
RNA isolation kit (Qiagen Pty Ltd, Australia) following 
the manufacturer’s instructions. Total RNA from tissues 
from the experimentally infected horses was isolated 
using MagMAX-96 Viral RNA Isolation Kit (Life Tech-
nologies). On column RNA clean-up was performed 
using DNase I digestion kit (Qiagen) following the manu-
facturer’s protocol. The quantity and quality of RNA was 
measured using NanoDrop 1000 spectrophotometer 
(Thermo Scientific, Australia). The isolated RNA was kept 
at −80 °C for further use. cDNA synthesis was performed 
using ‘qScript cDNA synthesis kit’ (cat. No: 95047-100, 
Quanta Biosciences) following the manufacturer’s proto-
col and stored at −20 °C until employed in transcriptome 
analysis using quantitative real time PCR (qRT-PCR). 
Primers for cytokines, TLRs and downstream genes, 
apoptosis and oxidative stress related genes, and two 
house-keeping genes (ACTB and GAPDH) were designed 
from FASTA products of the GenBank mRNA sequences 
for Equus caballus using the Primer3 program [34]. The 
WNVKUN specific primers were described earlier [35]. 
Details of the primers are given in Table  1. To quantify 
the mRNA expression for target and reference genes, 
qRT-PCR was performed using the Rotor Gene Corbett 
6000 quantitative real-time PCR system (Qiagen).
A two-step qRT-PCR was performed using Rotor-
Gene SYBR Green PCR Kit (Qiagen). Each run contained 
cDNA samples and a no-template control. qRT-PCR was 
set up using 1 μL of cDNA template, 10.5 μL of deionized 
RNase free water, 0.5  μM of upstream and downstream 
primers, and 12.5 μL of 2× Rotor-Gene SYBR Green PCR 
Master Mix (MM) (Qiagen) in a total reaction volume of 
25 μL. The cycling conditions included an initial PCR acti-
vation step (5 min at 95 °C), and a two-step cycling proto-
col, with a denaturation step and a combined annealing/
extension step. The two-step thermal cycling conditions 
were 5  s at 95  °C followed by 10  s at 60  °C (40 cycles). 
An amplification-based auto-threshold (Rotor-Gene 
Q Series Software, Qiagen) and adaptive baseline were 
selected as algorithms. Melting curve analysis was per-
formed to detect the specificity of the PCR reaction. Each 
sample was run twice and the average value was used as 
expression value. Gene-specific expression was measured 
as relative to the geometric mean of the expression of 
two housekeeping genes (GAPDH and ACTB) (Table 1). 
The delta Ct (�Ct)
[
�Ct = Cttarget − Cthouse keeping genes
]
 
values were calculated as the difference between target 
gene and reference genes and expression was calculated 
as 2(−∆∆Ct) [36]. Although the widely accepted delta delta 
Ct method has been used to calculate the relative gene 
expression, it is important to determine the PCR effi-
ciency for each transcript.
To compare the magnitude of gene expression, 
the fold change was calculated. For this purpose, the 
delta delta Ct (∆∆Ct) values were calculated as fol-
lows: Ct = CtWNV −Ctmock. The bar graphs in 
Figures  1, 2, 3, 4, 5, 6 and 7 and Additional file  1 show 
the expression of genes in WNV-stimulated PBMCs 
over mock-inoculated PBMCs (fold change: the nor-
malised expression value of a gene in WNV-stimu-
lated cells/the normalised expression value of a gene 
in mock-inoculated cells). Furthermore, accounting 
for the effects of culture conditions on gene transcrip-
tion in WNV- and mock-inoculated equine PBMCs, 
relative expression of genes between WNV-stimulated 
[CtWNV = CtWNV −Ctfresh] and mock-inoculated 
[Ctmock = Ctmock −Ctfresh] cells were analysed. 
For this purpose, tocompare the normalised expression 
of genes from PBMCs harvested at each time point to 
their respective expression levels before either WNV- or 
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Table 1 List of primers used in this study
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Table 1 continued





























a Annealing temperature was 60 °C for all the primer sets.
b Primer set is adopted from Beckman et al. [54].
c Kwon S et al. [55].
d Pyke et al. [35].
Figure 1 Expression kinetics of interferons mRNA. A Interferons expression in fold change. The ∆∆Ct [Ct = CtWNV −Ctmock] values 
were calculated by subtracting the ∆Ct of genes in mock‑inoculated PBMCs. The bar graph showed the expression of genes in WNV‑infected PBMCs 
over mock‑inoculated PBMCs (fold change: the normalised expression value of a gene in WNV‑stimulated cells/the normalised expression value of 
a gene in mock‑inoculated cells). Bars without common superscripts (A, B) denote statistical significant difference among time points (P < 0.05). 
B–D Relative expression of interferons mRNA, accounting for the effects of culture conditions on gene transcription in WNV‑ and mock‑inoculated 
equine PBMCs. To compare the normalised expression of interferon genes from PBMCs harvested at each time point to their respective expression 
levels before either WNV‑ or mock‑ inoculation, the ∆∆Ct values were calculated by subtracting ∆Ct of genes in fresh‑isolated PBMCs from the ∆Ct 
of genes in WNV‑ or mock‑ inoculated PBMCs at each time‑point (for WNV‑stimulated PBMCs, CtWNV = CtWNV −Ctfresh; and for mock‑inocu‑
lated PBMCs, Ctmock = Ctmock −Ctfresh). *P < 0.05.
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mock- inoculation, the ∆∆Ct values were calculated by 
subtracting ∆Ct of genes in fresh-isolated PBMCs from 
the ∆Ct of genes in WNV- or mock- inoculated PBMCs 
at each time-point.
Immunohistochemistry (IHC)
Immuno labeling for flavivirus NS1 antigen using the 
monoclonal antibody 4G4 has been previously described 
in [28]. Immunophenotyping of T-lymphocytes in 
inflammatory aggregates was achieved using cross-reac-
tive anti-human CD3 (CD3 clone F7.2.38, Dako) mouse 
monoclonal antibody following previously described pro-
tocols [37]. For each IHC batch, a positive and negative 
antigen control was included.
Virus growth kinetics quantification
The PBMCswere isolated from the three WNVKUN seron-
egative horses, as described above. Cells were diluted 
to 1  ×  105  cells/mL in RPMI supplemented with 10% 
FBS. One mlaliquots of cells were pelleted by centrifu-
gation, the supernatant discarded, and the cells resus-
pended with 100  µL medium containing 1  ×  105 PFU 
ofWNVNSW201 (MOI 1). The cells-virus suspension was 
incubated at 37 °C for 1 h for virus-adsorption. The sus-
pensionswere agitated every 15 min. Each 100 µL of cell-
virus suspension was then plated in one well of a 24-well 
cell culture plate, and 900 µL RPMI containing 10% FBS 
was added. The cells were incubated at 37  °C in a CO2 
incubator until the designated time of harvest (day 1, 2, 
Figure 2 Expression kinetics of cytokines mRNA. A–F Relative expression of cytokines mRNA, accounting for the effects of culture condi‑
tions on gene transcription in WNV‑ and mock‑inoculated equine PBMCs. To compare the normalised expression of cytokine genes from PBMCs 
harvested at each time point to their respective expression levels before either WNV‑ or mock‑ inoculation, the ∆∆Ct values were calculated by 
subtracting ∆Ct of genes in fresh‑isolated PBMCs from the ∆Ct of genes in WNV‑ or mock‑ inoculated PBMCs at each time‑point (for WNV‑stimulated 
PBMCs, CtWNV = CtWNV −Ctfresh; and for mock‑inoculated PBMCs, Ctmock = Ctmock −Ctfresh). *P < 0.05.
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3, and 4 pi). For the Vero cell positive control, DMEM 
with 5% FBS was used. Thermal-inactivation control 
involved addition of 1 × 105 PFU/mL of WNVNSW2011 to 
wells without the presence of cells. These control wells 
underwent the same conditions as the test wells. A well 
for each of three horses, a Vero cell positive control and 
a thermal-inactivation control was harvested every 24 h 
for 4 days pi. For complete removal of adherent PBMCs, 
lidocaine was used [32], whereas trypsinization was per-
formed for Vero cells. The virus concentration in super-
natant was quantified using standard plaque assay [4].
Detection of viral infectivity in PBMCs
The PBMCs harvested at 24  h pi were placed on two 
spots in circles drawn with a Dako pen on glass slides. 
The slides were air dried, formalin fixed and subjected to 
the immunolabelling protocol with monoclonal antibody 
4G4 described above, except for omission of the depar-
affinization steps.
Statistical analysis
In general the technical replicates were averaged. The 
impact of virus challenge (treatment) and duration of 
incubation (time points) were evaluated using the SAS 
software package v. 9.2 (SAS institute, Cary, NC, USA). 
For this purpose, the GLM (general linear model; Proc 
GLM) procedure and the implemented analysis of vari-
ance (ANOVA) statistic were used. Pairwise comparisons 
were performed between the time points and treatment 
groups, using Tukey’s multiple comparisons in SAS, 
where P value was simultaneously adjusted. Besides, 
student’s t test was applied when treatment groups were 
compared. The data were expressed as means ± standard 
deviations (SD) of biological repeats and (*) P < 0.05 were 
set as statistically significant.
Results
Expression of interferon and cytokine genes
Expression of the mRNA for IFNα, β and γ were higher 
in WNV-stimulated PBMCs at most time points from 2 
to 24 h compared to control PBMCs (Figure  1A). IFNα 
(Figure 1B) and IFNγ (Figure 1D) transcription were sig-
nificantly upregulated at 6  h, whereas IFNβ (Figure  1C) 
transcription was significantly increased at 24  h pi. The 
expression of mRNA for cytokines IL1α, IL1β, IL12, and 
IL22 was increased at most time points in WNV-stimu-
lated PBMCs compared to the mock-inoculated PBMCs 
(Additional file 1A). Pro-inflammatory cytokines IL6 and 
IL8 mRNA were increased 91 and 26 fold, respectively, at 
24 h pi in virus induced PBMCs. IL22 mRNA expression 
was 75 fold higher in WNV-stimulated PBMCs compared 
to mock-inoculated PBMCs, whereas steady state expres-
sion of TNFα and IL12 mRNA was observed over times 
(Additional file 1A). Although the PTX3 gene transcript 
was upregulated in WNV-infected PBMCsat 2 h pi, it was 
down-regulated at the later hours pi (Additional file 1A). 
When IL1 gene transcription was compared between 
WNV-stimulated and mock-inoculated PBMCs, IL1α 
(Figure  2A) and IL1β (Figure  2B) transcription patterns 
were similar in both the stimulated and control cells. 
Notably, IL1α and IL1β mRNA expression level in both 
WNV-stimulated and mock-inoculated PBMCs were 
highest at 6  h pi (Figures  2A  and B). IL6 (Figure  2C), 8 
(Figure 2D), and 22 (Figure 2E) mRNA transcription were 
Figure 3 Expression kinetics of TLRs mRNA. A–C Relative expres‑
sion of TLRs mRNA, accounting for the effects of culture conditions 
on gene transcription in WNV‑ and mock‑inoculated equine PBMCs. 
To compare the normalised expression of TLRs genes from PBMCs 
harvested at each time point to their respective expression levels 
before either WNV‑ or mock‑ inoculation, the ∆∆Ct values were cal‑
culated by subtracting ∆Ct of genes in fresh‑isolated PBMCs from the 
∆Ct of genes in WNV‑ or mock‑ inoculated PBMCs at each time‑point 
(for WNV‑stimulated PBMCs, CtWNV = CtWNV −Ctfresh; and for 
mock‑inoculated PBMCs, Ctmock = Ctmock −Ctfresh). *P < 0.05.
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higher at 24 h pi in WNV-stimulated PBMCs compared 
to mock-inoculated PBMCs, whereas PTX3 mRNA 
(Figure 2F) was upregulated at 2 h pi in the virus-stimu-
lated PBMCs.
Expression of Toll‑like receptors and associated 
downstream genes
The expression of TLR family (TLR1-10) gene transcripts 
was also quantified in WNV-infected equine PBMCs 
(Additional file 1B). TLR3, 5, 7, and 8 mRNA expression 
were increased early at 2 h pi, whereas TLR6 and 9 tran-
scription levels were higher at 12 h pi. In addition to the 
higher expression at 2  h, TLR8 mRNA was increased 
at 24  h pi, whereas TLR1 mRNA was increased at 24  h 
pi only (Additional file  1B). When TLR3 (Figure  3A), 
TLR7 (Figure 3B) and TLR9 (Figure 3C) mRNA expres-
sion in WNV-stimulated PBMCs was compared with 
mock-inoculated PBMCs, TLR3 mRNA expression 
level was higher at 6 and 12 h pi, whereas TLR7 and 9 
mRNA expression level were higher at 2  h pi. The time 
Figure 4 Expression kinetics of TLR-associated genes transcriptions. A–G Relative expression of mRNA for TLRs‑associated downstream 
genes, accounting for the effects of culture conditions on gene transcription in WNV‑ and mock‑inoculated equine PBMCs. To compare the 
normalised expression of TLRs‑associated genes from PBMCs harvested at each time point to their respective expression levels before either 
WNV‑ or mock‑ inoculation, the ∆∆Ct values were calculated by subtracting ∆Ct of genes in fresh‑isolated PBMCs from the ∆Ct of genes in WNV‑ 
or mock‑ inoculated PBMCs at each time‑point (for WNV‑stimulated PBMCs, CtWNV = CtWNV −Ctfresh; and for mock‑inoculated PBMCs, 
Ctmock = Ctmock −Ctfresh). *P < 0.05.
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course expression of other TLRs in virus-infected and 
mock-inoculated cells are presented in Additional file 2. 
Transcripts of all the downstream genes associated with 
signalling of those TLRs quantified were up to four times 
upregulated in WNV-stimulated PBMCs compared to 
mock-inoculated PBMCs (Additional file  1C). TRAF3, 
IRF3, STAT1 and NF-κB mRNA showed similar patterns 
of expressions in PBMCs in response to WNV challenge. 
ThemRNA expression of these genes was upregulated 
at 2  h as well as 24  h pi (Additional file  1C). MyD88 
(Figure  4A), TRAF3 (Figure  4B), STAT1 (Figure  4C), 
STAT2 (Figure  4D), IRF3 (Figure  4E), IRF7 (Figure  4F) 
and NF-κB (Figure 4G) mRNA were significantly upreg-
ulated in WNV-inoculated equine PBMCs compared to 
mock-inoculated PBMCs. Notably, STAT1 and 2 gene 
transcripts were upregulated from 2 h pi and during the 
remaining time of the experiment (Figures   4C  and D). 
Beside TLRs-associated genes, the ISG15, SOCS1 and 
SOCS3 genes were also upregulated in horse PBMC-
sin response to WNV challenge (Figure  5A). When 
these gene transcription levels were compared between 
WNV-inoculated and mock-inoculated PBMCs, ISG15, 
SOCS1 and SOCS3 mRNA were up-regulated at 24  h 
pi in stimulated PBMCs (Figures  5B–D). Additionally, 
SOCS3 mRNA was upregulated at 2 h pi in WNV-inocu-
lated PBMCs compared to mock-inoculated control cells 
(Figure  5D). Most of the gene transcription levels were 
found to be influenced by the time of stimulation and 
virus inoculation (Additional file 3).
HMOX1 and caspase 3 genes expression
Transcriptomes related to oxidative stress (HMOX1) and 
apoptotic pathway (caspase 3) were quantified in equine 
PBMCs. Although there was steady state expression of 
HMOX1 mRNA levels, the caspase 3 mRNA level was 
increased in WNV-stimulated PBMCs when compared 
to mock-inoculated PBMCs (Figure 6A). Caspase 3 gene 
expression was significantly higher in virus-stimulated 
PBMCs at 12 h pi (Figure 6B).
Quantification of selected gene transcripts and viral 
antigen detection in tissues from experimentally 
WNVNSW2011 infected horses
The mRNA expression patterns of selected genes (IFNα, 
β and γ, IL1β, IL22, PTX3, TNFα, ISG15, TLR3, TLR7, 
TLR9, MyD88, TRAF3, IRF7, STAT1 and 2) were also 
Figure 5 Expression kinetics of ISG15 and SOCS mRNA. A ISG and SOCS mRNA expression in fold change. The ∆∆Ct 
[Ct = CtWNV −Ctmock] values were calculated by subtracting the ∆Ct of genes in mock‑inoculated PBMCs. The bar graph showed the 
expression of genes in WNV‑infected PBMCs over mock‑inoculated PBMCs (fold change: the normalised expression value of a gene in WNV‑
stimulated cells/the normalised expression value of a gene in mock‑inoculated cells). Bars without common superscripts (A, B) denote statistical 
significant difference among time points (P < 0.05). B–D Relative expression of ISG15 and SCOS mRNA, accounting for the effects of culture condi‑
tions on gene transcription in WNV‑ and mock‑inoculated equine PBMCs. To compare the normalised expression of genes from PBMCs harvested 
at each time point to their respective expression levels before either WNV‑ or mock‑ inoculation, the ∆∆Ct values were calculated by subtracting 
∆Ct of genes in fresh‑isolated PBMCs from the ∆Ct of genes in WNV‑ or mock‑ inoculated PBMCs at each time‑point (for WNV‑stimulated PBMCs, 
CtWNV = CtWNV −Ctfresh; and for mock‑inoculated PBMCs, Ctmock = Ctmock −Ctfresh). *P < 0.05.
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assessed in lymphoid tissues (spleen, pre-scapular lymph 
node draining the inoculation site) and brain (Medulla 
oblongata) from horses experimentally infected with 
WNVNSW2011 [50], terminated 12  days pi (Figure  7). 
While all these genes were transcribed in the lymphoid 
tissues, particularly high mRNA levels were seen for 
IFNγ, IL22, ISG15 and IRF7 (Figure 7A). In brain tissue, 
IFNα, CXCL10, TLR3, ISG15 and IRF7 mRNA expres-
sions were also notably upregulated in the infected 
horses (Figure  7B). Notably, WNVNSW2011 RNA could 
not be detected in any tissues of infected horses (up to 
40 cycles). Nor was viral antigen detectable in the brain 
of the three infected horses terminated at 12  days pi 
(Figure  7C) despite signs of inflammation, with CD3+ 
T-lymphocytes marginating blood vessels, and infiltrat-
ing the perivascular spaces and neuropil of the Medulla 
oblongata (Figure 7D).
Virus growth kinetics in peripheral blood mononuclear 
cells
Viral RNA measurement showed higher levels of 
WNVNSW2011 RNA in WNV-inoculated equine PBMCs at 
24 h pi compared to 6 h pi (Figure 8A). No viral RNA was 
detected in mock-inoculated equine PBMCs and Ct were 
set to 40 for delta Ct (ΔCt) calculation. In order to assess 
the permissiveness of equine PBMCs to WNVNSW2011 
infection beyond the first 24  h, a 4-day (96  h) growth 
kinetics experiment was conducted. Virus titration by 
plaque assay was performed on PBMCs culture super-
natant. The 96 h growth kinetics curve showed that the 
virus titres from wells with challenged PBMCs did not 
differ significantly from that of the thermal inactivation 
culture (cell-free culture control) (Figure  8B). This sug-
gests that WNVNSW2011 did not productively replicate in 
equine PBMCs. The lack of NS1-specific immunolabe-
ling of WNVNSW2011-challenged equine PBMCs on day 
1 pi corroborated the failure of WNVNSW2011 to establish 
productive infection in equine PBMCs (Figure 8C). This 
contrasted with the high titres, as well as positive NS1-
immunolabeling, observed in supernatants and cell pel-
let, respectively, from virus inoculated Vero cells (positive 
control) (Figures  8C  and F). Mock-stimulated PBMCs 
immunostained using 4G4 as negative control are shown 
in Figure 8E.
Discussion
Understanding the expression kinetics of genes involved 
in the innate immune recognition of virus is important 
for understanding the host-pathogen interactions and 
pathogenesis of disease. TLRs and associated down-
stream gene products are amongst the key molecules rec-
ognising virus and initiating the inflammatory cascades 
and antiviral responses immediately upon infections [38]. 
Blood peripheral leukocytes are thought to be amongst 
the first cells to come into contact with mosquito-inocu-
lated WNV [27, 31] and thus PBMCs may act as the first 
line of defence against the virus. However, despite their 
potential importance, the interaction between WNV and 
equine PBMCs remains to be elucidated. As part of a 
greater aim to elucidate the genomic networks, this study 
identified the expression patterns of selected key genes 
in equine PBMCs following in  vitro challenge with an 
equine-virulent Australian strain of WNV.
Among the ten members of the TLR family (TLR1-10), 
TLR3, 7, 8 and 9 recognise viral genomic components 
[39]. TLR3 has been associated with the direct recog-
nition of double-stranded viral RNA, while TLR7 and 
TLR8 target single-stranded viral RNA [39]. The involve-
ment of TLR3 and TLR7 has been extensively studied for 
WNV infection and recognition in mice [9, 10]. In this 
study, TLR1, 3, 5, 7 and 9 mRNA expressionsall became 
Figure 6 Expression kinetics of Caspase 3 and HMOX1 mRNA. 
A Caspase 3 and HMOX1 mRNA expression in fold change. The ∆∆Ct 
[Ct = CtWNV −Ctmock] values were calculated by subtracting 
the ∆Ct of genes in mock‑inoculated PBMCs. The bar graph showed 
the expression of genes in WNV‑infected PBMCs over mock‑inocu‑
lated PBMCs (fold change: the normalised expression value of a gene 
in WNV‑stimulated cells/the normalised expression value of a gene 
in mock‑inoculated cells). Bars without common superscripts (A, B) 
denote statistical significant difference among time points (P < 0.05). 
B Relative expression of caspase 3mRNA, accounting for the effects 
of culture conditions on gene transcription in WNV‑ and mock‑
inoculated equine PBMCs. To compare the normalised expression 
of caspase 3 gene from PBMCs harvested at each time point to their 
respective expression levels before either WNV‑ or mock‑ inocula‑
tion, the ∆∆Ct value were calculated by subtracting ∆Ct of gene 
in fresh‑isolated PBMCs from the ∆Ct of gene in WNV‑ or mock‑ 
inoculated PBMCsat each time‑point (for WNV‑stimulated PBMCs, 
CtWNV = CtWNV −Ctfresh; and for mock‑inoculated PBMCs, 
Ctmock = Ctmock −Ctfresh). *P < 0.05.
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upregulated within 2–24  h of in  vitro virus challenge 
of horse PBMCs suggestive of their involvement in the 
WNV-induced innate immune response in this species. 
MyD88 and NF-κB mRNA expression likewise became 
upregulated in WNV-exposed equine PBMCs at 2  h pi. 
The partial WNV-recognition pathway has been sketched 
in mouse [8, 40] where WNV is being sensed by TLR3 
and 7. TLR3 and 7 lead to the activation of TRAF3 and 
MyD88, respectively. TRAF3 leads to the activation of 
IRF7, whereas IRF3 is activated by MyD88. IFN regula-
tory factors (IRFs) then lead to the production of IFNβ 
(reviewed in [8]). Subsequently, IFNβ and IFNα acti-
vate STAT1, STAT2 and IRF9, and these molecules then 
stimulate the transcription of antiviral genes such as the 
ISGs [8, 15]. The results of the present studies of equine 
PBMCs responses to WNV are in accordance with these 
pathways, with mRNA for TRAF3, IRF3, IRF7 and the 
STATs all being upregulated within 2  h post-challenge. 
While transcription of TLRs and associated genes 
were upregulated at early time points, ISG15 mRNA 
was upregulated at 24 h pi in the equine PBMCs in line 
with the time required to induce an antiviral state. This 
study identified higher expression of both Type-I (IFNα 
and IFNβ) and Type-II (IFNγ) IFNs in WNV-stimulated 
equine PBMCs compared to mock-inoculated PBMCs. 
The protective roles of IFNs in WNV infection have 
been widely studied in mice [41, 42]. Antiviral IFNs sig-
nal through the JAK/STAT pathway to induce ISG pro-
duction. ISGs can also be directly induced by some 
IRFs in an IFN-independent pathway [43]. Either way, 
the ISGs function to block virus replication [43]. IFNβ 
gene expression was also reported to be upregulated in 
WNVKUN-induced human blood monocyte derived den-
dritic cells at 24 h pi and then decreased at 48 and 72 h pi 
Figure 7 mRNA quantification and viral antigen detection in tissues from WNV-infected horses. A, B Quantification of selected genes 
transcripts in tissues from experimentally infected horses. A lymphoid tissues (draining lymph node, spleen) and (B) brain in fold change. To 
compare the gene expression between WNVNSW2011‑challenged and uninfected horses, fold change was calculated (fold change: the normalised 
expression value of a gene in WNV‑challenged horsecells/the normalised expression value of a gene in uninfected horse cells). C, D Immunolabe‑
ling of viral antigen and inflammatory cells in experimentally infected horse tissues. No viral antigen was detected (A) despite perivascular (arrow) 
and parenchymal infiltration of leukocytes, including CD3 + cells (D, red stain, arrow) in experimentally infected equine brain (Medulla oblongata). 
The results from horse no. 2 are presented and are representative of all three horses. Antigen of interest on both sections were visualised with AEC 
substrate (red product) and sections were counterstained with Meyer’s haematoxylin (Magnification: ×20).
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[7]. It is important to note that phosphorylation of IRF3 
in virus-infected cells can affect the virus-induced gene 
expression. TBK1 and IKKE are able to phosphorylate 
IRF3 and IRF7 in virus-infected cells, and can thereby 
control the IRF signalling pathway [44]. The phosphoryla-
tion related virus-induced down-stream genes expression 
Figure 8 Growth kinetics of WNVNSW2011and detection of viral antigen in equine PBMCs in vitro. A Viral RNA quantification in PBMCs 
using qRT‑PCR, (B) Virus replication in cells quantified using plaque assay. *PC: positive control, NC: negative control. Thermal inactivated curve is 
superimposed by the other lines. C WNV‑stimulated PBMCs immunostained using flavivirus NS1 specific monoclonal antibody 4G4, (D) WNV‑stimu‑
lated PBMCs immunostained without 4G4, (E) Mock‑stimulated PBMCs immunostained using 4G4 as negative control, and (F) WNV‑stimulated Vero 
immunostained using 4G4 as positive control. (Magnification: ×20). Arrow, indicated the perivascular regions.
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has not been verified in this study. Furthermore, SOCS 
are the physiological suppressors of cytokine signalling 
and form part of a classical feedback loop. SOCS1 and 
SOCS3 siRNA treated macrophages facilitated higher 
replication of WNV in the mouse [15] and up-regulation 
of SOCS1 and SOCS3 mRNA has been found in mouse 
in response to WNV infection [45]. Higher expressions of 
SOCS1 and 3 at 2 h pi may contribute to the restriction of 
WNV replication and balancing the immune responses 
of equine PBMCs in response to WNVNSW2011.
The present study involved infection of equine PBMCs 
with WNVNSW2011 at MOI 1. Styer et  al. [31] reported 
that mosquitoes typically inoculate  ~102  PFU directly 
into the blood while probing and feeding and thus circu-
lating PBMCs are amongst the first cells to be exposed to 
WNV. We found that higher viral RNA was detected at 
24 h pi compared to 6 h pi in equine PBMCs. Therefore, 
an extended experiment up to 4 days pi was conducted, 
in order to investigate whether WNVNSW2011 can pro-
ductively replicate in equine PBMCs. It is important to 
note that for successful replication, viruses will required 
several hours to complete the replication cycle, which 
includes production of mature virions and subsequently 
exocytosis from cells as infectious viral particles [46]. Fol-
lowing a mosquito bite, the initial WNV infection and 
spread (the early phase) and peripheral viral amplifica-
tion (the visceral-organ dissemination phase) may take 
up to 4  days [40]. Therefore, virus was not quantified 
using plaque assay in this study until 24  h pi and later. 
Interestingly, we found that WNVNSW2011 did not repli-
cate in the equine PBMCs, which was further supported 
by the lack of expression of viral NS1 at 24 h pi. Although 
in vitro WNV inoculation by passes the host-virus inter-
faces in the skin, the host-viral interactions of virus deliv-
ered into the blood might be represented by the type of 
study employed here. In this context, the higher expres-
sion of Type I IFNs and ISG15 in the first 24  h pi may 
explain the inhibition of viral replication or growth in 
equine PBMCs. These early virus restriction mecha-
nisms may point to a natural resistance mechanism(s) in 
this species and are in accordance with the fact that the 
majority of infections in horses are subclinical [1].
Rawle et  al. [7] compared the growth kinetics of 
WNVNSW2011 and WNVNY99 using plaque assay and 
found that WNVNSW2011 did not replicate in human blood 
monocyte derived dendritic cells as they extended the 
experiment from 24 to 72  h pi, whereas WNVNY99 suc-
cessfully replicated in these cells for the duration of the 
experiment. The successful replication of WNVNY99 has 
also been reported in equine PBMCs [27], where in vitro 
equine PBMCs were infected for 10–14  days pi. Since 
other studies [7, 27] did not quantify viral RNA during 
the first 24  h pi, a comparison to our findings of viral 
RNA detection is precluded. Our results of WNVNSW2011 
growth kinetics, quantified using plaque assay, corrobo-
rates the growth kinetics of this virus strain reported by 
Rawle et  al. [7] but differs from the growth kinetics of 
WNVNY99 reported by Rawle et al. [7] and Gracia-Tapia 
et  al. [27], respectively. Whether these differences in 
growth kinetics in leukocytes between WNVNSW2011 and 
WNVNY99 maybe ascribed to virus characteristics sensu 
stricto or may be explained by their respective ability to 
induce protective innate immune responses remains to 
be elucidated.
Other than IFNs (both Type I and Type II), transcripts 
for several cytokines were found to be upregulated in 
response to WNV stimulation of equine PBMCs, includ-
ing IL1α, IL1β, IL6 and IL8. Studies with IL1R1 knockout 
mice have demonstrated that IL1 is critical for limiting 
WNV-induced encephalitis in the murine model, pur-
portedly via a T cell activation mechanism [47] and mice 
inoculated intraperitoneally with WNVNY99 had upregu-
lation of IL6 and IL12 transcripts [48]. It is important to 
note that when traditional fold changes are calculated to 
demonstrate gene expression, the culture conditions may 
confound the results. Therefore, in addition to the tradi-
tional method (Figures 1A, 5A, and 6A; Additional file 1), 
we compared the normalized expression of cytokine 
genes from PBLs harvested at each time point to their 
respective expression levels before either WNV or mock 
inoculation (Figures  1B–D, 2A–F, 3A–C, 4A–G, 5B–D, 
6B; Additional file 2). This method display the temporal 
kinetics of cytokine gene transcription in mock-inocu-
lated PBLs, which in turn can reveal background effects 
of culture conditions on gene transcription in the WNV-
challenged PBLs. Using this approach, we demonstrated 
that IL1α, IL1β and IL6 mRNA expression levels were 
increased in both sets of culture conditions.
A holistic transcriptome expression study using 
microarray found higher expression of IL12, IL22, 
SOCS3 and PTX3 in the thalamus of experimentally 
WNVNY99-infected horses [18]. Similar to the in  vitro 
experiment, we found that transcription of selected 
cytokine genes was upregulated in brain, spleen and 
draining lymph node of experimentally WNVNSW2011-
infected horses. We found that while IFNγ and IL22 
mRNA expression level was higher in lymphoid tis-
sues (lymph node and spleen), their expression level 
was lower in CNS in experimentally WNVNSW2011-
infected horse. It has been suggested that IL22 exacer-
bates lethal WNVNY99 encephalitis by promoting virus 
neuro invasion in mice [49]. Therefore, lower expres-
sion of IL22 and higher expression of antiviral IFNα 
in equine brain at 12  days pi may explain the absence 
of viral antigen in the brain of experimentally infected 
horse in this study. Notably, higher expression of IL22 
Page 14 of 16Uddin et al. Vet Res  (2016) 47:61 
in experimentally infected horse tissues (spleenand 
lymph node) coincided with the expression of this gene 
in experimentally infected horse thalamus [18] imply-
ing that species is also an important factor to be con-
sidered. Furthermore, despite mild inflammations in 
the CNS, no viral antigen was detected by IHC and 
qRT-PCR, suggesting virus clearance by at least 12 days 
pi. Similar results have been demonstrated in other 
studies in both experimentally and naturally infected 
horses [20, 21, 50]. It remains to be established exactly 
what role each individual cytokine plays in virus con-
trol and inflammation in equine WNV encephalitis, but 
the prominent transcription of the chemokine ligand 
CXCL10 in the experimentally infected equine brain 
may at least explain the CD3+ cell infiltrates in the 
brain.
Caspase 3 mRNA expression was increased over time 
in equine PBMCs in response to in  vitro WNVNSW2011. 
WNV has been reported to induce apoptosis in human 
brain derived glia cells in culture by the activation of cas-
pase 3, 8 and 9 [51] but so far there has been no study 
that quantified caspase expression in equine PBMCs fol-
lowing WNV challenge. Higher expression of caspase 3 
mRNA in in  vitro infected equine PBMCs is in accord-
ance with other studies [51, 52] establishing that caspase 
3-dependent apoptosis might be involved in WNV infec-
tion. It remains to be shown that the equine cells proceed 
to undergo apoptosis following WNV exposure in  vitro 
and in  vivo. On the other hand, comparatively lower 
expression of TNFα and HMOX1 mRNA in this study 
suggests that oxidative stress may not be important in 
WNVNSW2011 induced early immune responses in equine 
PBMCs.
Mosquito-borne diseases are a major human and ani-
mal health issue globally as well as in Australia. The soci-
oeconomic importance of these diseases to the equine 
industries is substantial and their impact is predicted to 
increase in some regions due to changes in vector breed-
ing associated with climate change. This has been well 
demonstrated by the unprecedented outbreak of WNV 
encephalitis in horses in SE Australia in 2011 following 
flooding of many eastern regions of Australia. Although 
the expression of most of the genes studied here was 
similar to those found in the mouse model, the murine 
immune response to WNV may not necessarily reflect 
the immune responses in human and horse [19, 53]. 
Therefore, studies in horse PBMCs may provide a better 
understanding of the early interactions between host cells 
and viruses, at least as far as horses are concerned.The 
expression kinetics of the selected transcriptomes illus-
trates a partial pathway by which WNV is detected by the 
host immune system. Further studies will be required to 
elucidate the complete network of antiviral defences.
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Additional file 1.  Expression kinetics of cytokines, TLRs and TLR-
associatedgenes in equine PBMCs in response to West Nile virus in 
fold change. A) Cytokines expression in fold change. The ∆∆Ct [∆∆Ct = 
∆CtWNV ‑ ∆Ctmock] values were calculated by subtracting the ∆Ct of genes 
in mock‑inoculated PBMCs. The bar graph showed the expression of 
genes in WNV‑infected PBMCs over mock‑inoculated PBMCs (fold change: 
the normalised expression value of a gene in WNV‑stimulated cells / the 
normalised expression value of a gene in mock‑inoculated cells). Bars 
without common superscripts (A, B) denote statistical significant differ‑
ence among time points (P < 0.05). B) Toll‑like receptors expression in 
fold change. The ∆∆Ct [∆∆Ct = ∆CtWNV ‑ ∆Ctmock] values were calculated 
by subtracting the ∆Ct of genes in mock‑inoculated PBMCs. The bar 
graph showed the expression of genes in WNV‑infected PBMCs over 
mock‑inoculated PBMCs (fold change: the normalised expression value 
of a gene in WNV‑stimulated cells / the normalised expression value of a 
gene in mock‑inoculated cells). Bars without common superscripts (A, B) 
denote statistical significant difference among time points (P < 0.05). C) 
TLRs‑associated downstream genes expression in fold change. The ∆∆Ct 
[∆∆Ct = ∆CtWNV ‑ ∆Ctmock] values were calculated by subtracting the ∆Ct 
of genes in mock‑inoculated PBMCs. The bar graph showed the expres‑
sion of genes in WNV‑infected PBMCs over mock‑inoculated PBMCs (fold 
change: the normalised expression value of a gene in WNV‑stimulated 
cells / the normalised expression value of a gene in mock‑inoculated 
cells). Bars without common superscripts (A, B) denote statistical signifi‑
cant difference among time points (P < 0.05).
Additional file 2. Time-depended relative expression of TLRs 
mRNAs in equine PBMCs in response to West Nile virus. Description 
of data: Relative expression of TLRs mRNA, accounting for the effects of 
culture conditions on gene transcription in WNV‑ and mock‑inoculated 
equine PBMCs. To compare the normalised expression of TLRs genes from 
PBMCs harvested at each time point to their respective expression levels 
before either WNV‑ or mock‑ inoculation, the ∆∆Ct values were calculated 
by subtracting ∆Ct of genes in fresh‑isolated PBMCs from the ∆Ct of genes 
in WNV‑ or mock‑ inoculated PBMCs at each time‑point (for WNV‑stimu‑
lated PBMCs, ∆∆CtWNV = ∆CtWNV ‑ ∆Ctfresh; and for mock‑inoculated PBMCs, 
∆∆Ctmock = ∆Ctmock ‑ ∆Ctfresh). *P<0.05.
Additional file 3. Effect of time and virus stimulation on the rela-
tive expression of genes. Summary of the Proc GLM (SAS) analysis 
detecting effect of time and virus stimulation on the mRNA expressions 
level of genes. Adjusted P‑values are mentioned in the columns for time 
of WNV‑inoculation, WNV‑stimulation, and the interaction of incubation 
time and virus stimulation.
Page 15 of 16Uddin et al. Vet Res  (2016) 47:61 
of Chemistry and Molecular Biosciences, The University of Queensland, St 
Lucia, QLD, Australia. 4 Australian Infectious Diseases Research Centre, The 
University of Queensland, St Lucia, QLD, Australia. 
Received: 3 August 2015   Accepted: 17 May 2016
References
 1. Angenvoort J, Brault AC, Bowen RA, Groschup MH (2013) West Nile viral 
infection of equids. Vet Microbiol 167:168–180
 2. Doherty RL, Carley JG, Mackerras MJ, Marks EN (1963) Studies of arthro‑
pod‑borne virus infections in Queensland. III. Isolation and characteriza‑
tion of virus strains from wild‑caught mosquitoes in North Queensland. 
Aust J Exp Biol Med Sci 41:17–39
 3. Hall RA, Broom AK, Smith DW, Mackenzie JS (2002) The ecology and 
epidemiology of Kunjin virus. Curr Top Microbiol Immunol 267:253–269
 4. Frost MJ, Zhang J, Edmonds JH, Prow NA, Gu X, Davis R, Hornitzky C, 
Arzey KE, Finlaison D, Hick P, Read A, Hobson‑Peters J, May FJ, Doggett 
SL, Haniotis J, Russell RC, Hall RA, Khromykh AA, Kirkland PD (2012) 
Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. 
Emerging Infect Dis 18:792–800
 5. CDC (2012) West Nile virus disease cases and deaths reported to CDC by 
year and clinical presentation, 1999–2012. http://www.cdc.gov/westnile/
resources/pdfs/cummulative/99_2013_CasesAndDeathsClinicalPresenta‑
tionHumanCases.pdf
 6. Prow NA, Hewlett EK, Faddy HM, Coiacetto F, Wang W, Cox T, Hall RA, 
Bielefeldt‑Ohmann H (2014) The Australian public is still vulnerable to 
emerging virulent strains of West Nile virus. Front Public Health 2:146
 7. Rawle DJ, Setoh YX, Edmonds JH, Khromykh AA (2015) Comparison of 
attenuated and virulent West Nile virus strains in human monocyte‑
derived dendritic cells as a model of initial human infection. Virol J 12:46
 8. Diamond MS, Gale M Jr (2012) Cell‑intrinsic innate immune control of 
West Nile virus infection. Trends Immunol 33:522–530
 9. Daffis S, Samuel MA, Suthar MS, Gale M Jr, Diamond MS (2008) Toll‑like 
receptor 3 has a protective role against West Nile virus infection. J Virol 
82:10349–10358
 10. Welte T, Reagan K, Fang H, Machain‑Williams C, Zheng X, Mendell N, 
Chang GJ, Wu P, Blair CD, Wang T (2009) Toll‑like receptor 7‑induced 
immune response to cutaneous West Nile virus infection. J Gen Virol 
90:2660–2668
 11. Demento SL, Bonafe N, Cui W, Kaech SM, Caplan MJ, Fikrig E, Ledizet 
M, Fahmy TM (2010) TLR9‑targeted biodegradable nanoparticles as 
immunization vectors protect against West Nile encephalitis. J Immunol 
185:2989–2997
 12. Szretter KJ, Daffis S, Patel J, Suthar MS, Klein RS, Gale M Jr, Diamond MS 
(2010) The innate immune adaptor molecule MyD88 restricts West Nile 
virus replication and spread in neurons of the central nervous system. J 
Virol 84:12125–12138
 13. Apostolou E, Thanos D (2008) Virus Infection Induces NF‑kappaB‑depend‑
ent interchromosomal associations mediating monoallelic IFN‑beta gene 
expression. Cell 134:85–96
 14. Perwitasari O, Cho H, Diamond MS, Gale M Jr (2011) Inhibitor of kappaB 
kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate 
immune effector pathway against West Nile virus infection. J Biol Chem 
286:44412–44423
 15. Dai J, Pan W, Wang P (2011) ISG15 facilitates cellular antiviral response to 
dengue and west nile virus infection in vitro. Virol J 8:468
 16. Daffis S, Samuel MA, Suthar MS, Keller BC, Gale M Jr, Diamond MS (2008) 
Interferon regulatory factor IRF‑7 induces the antiviral alpha interferon 
response and protects against lethal West Nile virus infection. J Virol 
82:8465–8475
 17. Sabouri AH, Marcondes MC, Flynn C, Berger M, Xiao N, Fox HS, Sarvetnick 
NE (2014) TLR signaling controls lethal encephalitis in WNV‑infected 
brain. Brain Res 1574:84–95
 18. Bourgeois MA, Denslow ND, Seino KS, Barber DS, Long MT (2011) Gene 
expression analysis in the thalamus and cerebrum of horses experimen‑
tally infected with West Nile virus. PLoS One 6:e24371
 19. Graham JB, Thomas S, Swarts J, McMillan AA, Ferris MT, Suthar MS, 
Treuting PM, Ireton R, Gale M Jr, Lund JM (2015) Genetic diversity in the 
collaborative cross model recapitulates human west nile virus disease 
outcomes. MBio 6:493–515
 20. Bunning ML, Bowen RA, Cropp CB, Sullivan KG, Davis BS, Komar N, God‑
sey MS, Baker D, Hettler DL, Holmes DA, Biggerstaff BJ, Mitchell CJ (2002) 
Experimental infection of horses with West Nile virus. Emerging Infect Dis 
8:380–386
 21. Cantile C, Del Piero F, Di Guardo G, Arispici M (2001) Pathologic and 
immunohistochemical findings in naturally occuring West Nile virus 
infection in horses. Vet Pathol 38:414–421
 22. Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL (2010) West Nile fever 
characteristics among viremic persons identified through blood donor 
screening. J Infect Dis 202:1354–1361
 23. Suen WW, Uddin MJ, Wang W, Brown V, Adney D, Broad N, Prow NA, Hall 
RA, Bowen RA, Bielefeldt‑Ohmann H (2015) Experimental West Nile virus 
infection in rabbits: an alternative model for studying mechanism of non‑
lethal meningoencephalitis and virus control. Pathogens 4:529–558
 24. Suen WW, Prow NA, Setoh YX, Hall RA, Bielefeldt‑Ohmann H (2016) End‑
point disease investigation for virus strains of intermediate virulence as 
illustrated by flavivirus infections. J Gen Virol 97:366–377
 25. Uddin MJ, Suen WW, Prow NA, Hall RA, Bielefeldt‑Ohmann H (2015) West 
Nile virus challenge alters the transcription profiles of innate immune 
genes in rabbit peripheral blood mononuclear cells. Front Vet Sci 2:76
 26. Quicke KM, Suthar MS (2013) The innate immune playbook for restricting 
West Nile virus infection. Viruses 5:2643–2658
 27. Garcia‑Tapia D, Loiacono CM, Kleiboeker SB (2006) Replication of West 
Nile virus in equine peripheral blood mononuclear cells. Vet ImmunolIm‑
munopathol 110:229–244
 28. Prow NA, Setoh YX, Biron RM, Sester DP, Kim KS, Hobson‑Peters J, Hall RA, 
Bielefeldt‑Ohmann H (2014) The West Nile virus‑like flavivirus Koutango is 
highly virulent in mice due to delayed viral clearance and the induction 
of a poor neutralizing antibody response. J Virol 88:9947–9962
 29. Bielefeldt‑Ohmann H, Prow NA, Wang W, Tan CS, Coyle M, Douma A, 
Hobson‑Peters J, Kidd L, Hall RA, Petrovsky N (2014) Safety and immuno‑
genicity of a delta inulin‑adjuvanted inactivated Japanese encephalitis 
virus vaccine in pregnant mares and foals. Vet Res 45:130
 30. Uddin MJ, Nuro‑Gyina PK, Islam MA, Tesfaye D, Tholen E, Looft C, Schel‑
lander K, Cinar MU (2012) Expression dynamics of Toll‑like receptors 
mRNA and cytokines in porcine peripheral blood mononuclear cells 
stimulated by bacterial lipopolysaccharide. Vet Immunol Immunopathol 
147:211–222
 31. Styer LM, Kent KA, Albright RG, Bennett CJ, Kramer LD, Bernard KA (2007) 
Mosquitoes inoculate high doses of West Nile virus as they probe and 
feed on live hosts. PLoS Pathog 3:1262–1270
 32. Ohmann HB, Gilchrist JE, Babiuk LA (1984) Effect of recombinant DNA‑
produced bovine interferon alpha (BoIFN‑alpha 1) on the interaction 
between bovine alveolar macrophages and bovine herpesvirus type 1. J 
Gen Virol 65:1487–1495
 33. Bielefeldt‑Ohmann H, Bosco‑Lauth A, Tolany A‑E, Edwards J, Prow NA, 
Wang W, Khromykh AA, Hall RA, Kirkland PD, Bowen RA (2013) Experi‑
mental infectiou of horses with the equine‑pathogeneic West Nile Virus 
strain WNVNSW2011. AVS (Australian Virology Society) Meeting 7, 8–11 
December 2013, Queenstown, New Zealand
 34. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and 
for biologist programmers. Methods Mol Biol 132:365–386
 35. Pyke AT, Smith IL, van den Hurk AF, Northill JA, Chuan TF, Westacott 
AJ, Smith GA (2004) Detection of Australasian Flavivirus encephalitic 
viruses using rapid fluorogenic TaqMan RT‑PCR assays. J Virol Methods 
117:161–167
 36. Pfaffl MW (2001) A new mathematical model for relative quantification in 
real‑time RT‑PCR. Nucleic Acids Res 29:e45
 37. Tolnay AE, Baskin CR, Tumpey TM, Sabourin PJ, Sabourin CL, Long JP, Pyles 
JA, Albrecht RA, Garcia‑Sastre A, Katze MG, Bielefeldt‑Ohmann H (2010) 
Extrapulmonary tissue responses in cynomolgus macaques (Macaca 
fascicularis) infected with highly pathogenic avian influenza A (H5N1) 
virus. Arch Virol 155:905–914
 38. Arjona A, Wang P, Montgomery RR, Fikrig E (2011) Innate immune control 
of West Nile virus infection. Cell Microbiol 13:1648–1658
Page 16 of 16Uddin et al. Vet Res  (2016) 47:61 
 39. Kawai T, Akira S (2011) Toll‑like receptors and their crosstalk with other 
innate receptors in infection and immunity. Immunity 34:637–650
 40. Suthar MS, Diamond MS, Gale M Jr (2013) West Nile virus infection and 
immunity. Nat Rev Microbiol 11:115–128
 41. Samuel MA, Diamond MS (2005) Alpha/beta interferon protects against 
lethal West Nile virus infection by restricting cellular tropism and enhanc‑
ing neuronal survival. J Virol 79:13350–13361
 42. Shrestha B, Wang T, Samuel MA, Whitby K, Craft J, Fikrig E, Diamond MS 
(2006) Gamma interferon plays a crucial early antiviral role in protection 
against West Nile virus infection. J Virol 80:5338–5348
 43. Schoggins JW, Rice CM (2011) Interferon‑stimulated genes and their 
antiviral effector functions. Curr Opin Virol 1:519–525
 44. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, 
Coyle AJ, Liao SM, Maniatis T (2003) IKKepsilon and TBK1 are essential 
components of the IRF3 signaling pathway. Nat Immunol 4:491–496
 45. Mansfield KL, Johnson N, Cosby SL, Solomon T, Fooks AR (2010) Tran‑
scriptional upregulation of SOCS 1 and suppressors of cytokine signaling 
3 mRNA in the absence of suppressors of cytokine signaling 2 mRNA 
after infection with West Nile virus or tick‑borne encephalitis virus. Vector 
Borne Zoonotic Dis 10:649–653
 46. Brinton MA (2002) The molecular biology of West Nile Virus: a new 
invader of the western hemisphere. Annu Rev Microbiol 56:371–402
 47. Durrant DM, Robinette ML, Klein RS (2013) IL‑1R1 is required for dendritic 
cell‑mediated T cell reactivation within the CNS during West Nile virus 
encephalitis. J Exp Med 210:503–516
 48. Pena J, Plante JA, Carillo AC, Roberts KK, Smith JK, Juelich TL, Beasley DW, 
Freiberg AN, Labute MX, Naraghi‑Arani P (2014) Multiplexed digital mRNA 
profiling of the inflammatory response in the West Nile Swiss Webster 
mouse model. PLoS Neg Trop Dis 8:e3216
 49. Wang P, Bai F, Zenewicz LA, Dai J, Gate D, Cheng G, Yang L, Qian F, Yuan 
X, Flavell Montgomery RR, RA, Town T, Fikrig E, (2012) IL‑22 signaling 
contributes to West Nile encephalitis pathogenesis. PLoS One 7:e44153
 50. Suen WW, Prow NA, Hall RA, Bielefeldt‑Ohmann H (2014) Mechanism of 
West Nile virus neuroinvasion: a critical appraisal. Viruses 6:2796–2825
 51. Kleinschmidt MC, Michaelis M, Ogbomo H, Doerr HW, Cinatl J Jr (2007) 
Inhibition of apoptosis prevents West Nile virus induced cell death. BMC 
Microbiol 7:49
 52. Samuel MA, Morrey JD, Diamond MS (2007) Caspase 3‑dependent cell 
death of neurons contributes to the pathogenesis of West Nile virus 
encephalitis. J Virol 81:2614–2623
 53. Mestas J, Hughes CC (2004) Of mice and not men: differences between 
mouse and human immunology. J Immunol 172:2731–2738
 54. Beekman L, Tohver T, Dardari R, Leguillette R (2011) Evaluation of suitable 
reference genes for gene expression studies in bronchoalveolar lavage 
cells from horses with inflammatory airway disease. BMC Mol Biol 12:5
 55. Kwon S, Gewirtz AT, Hurley DJ, Robertson TP, Moore JN, Vandenplas ML 
(2011) Disparities in TLR5 expression and responsiveness to flagel‑
lin in equine neutrophils and mononuclear phagocytes. J Immunol 
186:6263–6270
